Resident Research Program

 

VETERINARY CANCER SOCIETY

SPONSORED RESIDENT RESEARCH ANNOUNCEMENT

Call for clinical/basic research proposals

 

OVERVIEW:

The Veterinary Cancer Society (VCS) is pleased to announce research support for residents participating in an ACVIM-approved training programs in the form of unrestricted research gifts of up to $20,000 to perform hypothesis driven, prospective studies that will require approximately one year to complete.  Additionally, each year, an opportunity for “sponsored” awards may be available (see section G, “Sponsored Awards” below).

ELIGIBILITY:

  • Any resident participating in an ACVIM-approved training program is eligible to apply.
  • Either clinical or basic research projects in the field of veterinary and/or comparative oncology are eligible for consideration.
  • Must be a current member of the Veterinary Cancer Society and remain so for the duration of the trial.

CRITERIA FOR AWARD SELECTION:

  • Proposals will be reviewed by a committee comprised of VCS members with expertise in clinical and basic veterinary oncology research (see VCS website for committee membership).
  • Specific criteria used in consideration of proposals will include:
    • Potential of the study to enhance existing scientific knowledge in the field of veterinary and/or comparative oncology
    • Relevance of the proposal to existing scientific knowledge
    • Feasibility of the study, including: likelihood of success in achieving study objectives and obtaining publishable results; appropriateness of study design; realistic time frame for completion (e.g., institutional case load for clinical proposals)
    • Adequacy of facility space/infrastructure/equipment, prior research productivity
    • Adequacy of Animal Involvement Justification (Protection/Safety)

PROPOSAL GUIDELINES

A complete application in the form of a single pdf file must be submitted by email attachment before midnight on January 15th, 2017 to vetcancersociety@yahoo.com. 

Document format:

  • Proposals should be written on 8.5 × 11 inch paper with a minimum of 3⁄4 inch margin.
  • Single-spaced using no smaller than an 11-point Times New Roman font.
  • Page limits for each section must be strictly observed.
  • The order of the written proposal should follow the outline described below, including use of the outline numbering and headings.
  • If any of the sections are not applicable, indicate this with “N/A”.
  • Figures, tables and graphics must be included in the “Study Proposal” page limit. Addenda and extra information beyond the page limit will not be reviewed.
  • Failure to adhere to these guidelines will result in disqualification.

Proposal structure and limits:

A.  Cover page (1-page max): Title of proposed study; name, affiliation (academic/practice entity), email, and postal mailing address of the resident, resident advisor, all investigators; name of the agency to which the grant would be payable; amount requested; signature of the resident, Resident Advisor and appropriate grant administrator(s)

B.  Study Proposal (5-page limit including the headings outlined below):

  1. Summary (1-page max): To include:
    1. Title
    2. Hypothesis/Objective(s)
    3. Relevance statement (description of problem and need for the research being proposed)
  1. Research Strategy (3 pages max): To include:
    1. Background and significance
    2. Preliminary data (if applicable)
    3. Experimental design and methods
    4. Analysis (statistical methods, sample size justification if applicable)
    5. Expected results
    6. Resources and Timeline for completion
  1. Budget and justification (1-page max): Allowable items:
    1. Personnel –salary for resident and advisor are not allowed. Technician, data management individuals may be allowable
    2. Equipment – purchase of major equipment is not allowable.
    3. Supplies
    4. Patient care costs (if applicable)
    5. Other expenses
    6. Indirect costs: as this is an unrestricted gift, indirect costs are not allowable.

C.  References (1-page maximum): Pertinent related literature references

D.  Biographical sketch (2 pages each maximum): NIH style biosketch of Resident, Resident-advisor and any co-investigators

E.  Client consent form (2-page maximum) if applicable: Copy of proposed client consent form

F.  Resident Advisor statement (1-page): The residency advisor must sign off on the project in the form of letter stating:

  1. A willingness to ensure completion of the project in the 1-year time-frame
  2. A commitment to have the completed project presented (by the resident) in the form or either an oral or poster presentation at a VCS meeting within 2 years of project funding.
  3. A commitment to provide a progress report within 1-year of funding.
  4. Animal Involvement:  The study should be approved by an Institutional Animal Care and Use Committee (IACUC) and documentation of this approval (or pending approval) must be provided in the event the funding is awarded.  If there is no applicable IACUC approval process available at the institution/entity, the VCS will provide a mechanism for similar approval.

G.  Sponsored Awards (2016-2017): In addition to up to two non-sponsored projects to be considered for this grant cycle, two additional projects will be funded, one each involving the two sponsored products outlined below. Guidelines for sponsored awards are the same as for non-sponsored awards.

Immunocidin® (NovaVive)

Immunocidin is a veterinary biologic licensed for the treatment of mixed mammary tumors and mammary adenocarcinomas in dogs. It is based on a proprietary mycobacterial cell wall technology platform, derived from Mycobacterium phlei. Additional information can be found at: http://novavive.ca/product/U.S.A./immunocidin-canine. Project will provide $20,000 in funding along with product to treat up to 80 dogs and 40 cats.

Thermofield® Noninvasive Deep Tissue Heating System (Midmark Animal Health)

The Thermofield technology transfers a large volume of electromagnetic energy deep into biological tissue using state-of-the art applicator technology. The system makes the delivery of therapeutic hyperthermia safe and easy to use. Additional information can be found at: http://thermofield.com/product.

Project will provide $20,000 in funding along with a Thermofield hyperthermia on loan to use during the study.

TIMELINES:

  • Application announcement: At the October 2016 VCS Annual Meeting and simultaneously on the VCS website.
  • Deadline for Receipt of Applications: January 15, 2017.
  • Award Announcements: March 1st, 2017.
  • Funding to begin: April 1st, 2017.

SUBMISSION VIA EMAIL (PDF) to vetcancersociety@yahoo.com.